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Abstract
Irritable bowel syndrome (IBS) is one of the most 
common gastrointestinal disorders, having a prevalence 
of 12%-30% in the general population. Most patients 
with IBS attribute their symptoms to adverse food 
reactions. We review the role of diet in the pathogenesis 
of IBS and the importance of dietary factors in the 
management of these patients. The MEDLINE electronic 
database (1966 to Jan 2015) was searched using 
the following keywords: “food”, “diet”, “food allergy”, 
“food hypersensitivity”, “food intolerance”, “IBS”, 
“epidemiology”, “pathogenesis”, “pathophysiology”, 
“diagnosis”, “treatment”. We found 153 eligible papers; 
80 were excluded because: not written in English, 
exclusive biochemical and experimental research, case 
reports, reviews, and research otherwise not relevant to 
our specific interest. We selected 73 papers: 43 original 
papers, 26 reviews and 4 letters to the editor. These 
papers focused on IBS pathogenesis, the association 
between IBS and atopy, and between IBS and food 
allergy, the relationship between IBS and non-celiac 
wheat sensitivity, the role of diet in IBS. Pending further 
scientific evidence, a cautious approach is advisable 
but the concept of food allergy should be included as a 
possible cause of IBS, and a dietary approach may have 
a place in the routine clinical management of IBS.
Key words: Irritable bowel syndrome; Food allergy; 
Food intolerance; Non-celiac wheat sensitivity; Atopy; 
Asthma; Elimination diet
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Core tip: Starting from the late evidences about the 
non-celiac wheat sensitivity, we reviewed the role of 
diet in the pathogenesis of irritable bowel syndrome and 
the importance of dietary factors in the management of 
these patients. We found 183 papers about the matter, 
selecting 73 for review. We concluded that food allergy 
could be a possible cause of irritable bowel syndrome, 
and a dietary approach should be implemented in 
clinical practice.
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INTRODUCTION
With prevalence ranging from 12%-30% of the general 
population, and even if it is only 5%-10% using recent 
diagnostic criteria, irritable bowel syndrome (IBS) is one 
of the most common gastrointestinal disorders. The 
disease is usually diagnosed in younger patients (i.e., 
< 50 years of age) and is more common in women[1,2]. 
It has always been counted among the chronic 
functional gastrointestinal disorders, characterized by 
abdominal discomfort or pain, abnormal bowel habits, 
and often bloating and abdominal distension. Symptom 
patterns remain the cornerstone of diagnosis and 
classification of functional gut disorders (i.e., the Rome 
Ⅲ criteria). They may be categorized as diarrhea-
predominant (D-IBS), constipation-predominant 
(C-IBS), mixed diarrhea and constipation (M-IBS), and 
unclassified (U-IBS) IBS[3,4]. Although IBS does not 
seem to be associated with the development of serious 
diseases or mortality, it reduces the patient’s quality of 
life considerably. Symptom severity varies in different 
patients, from tolerable to severe, interfering with daily 
activity, causing an impairment similar to some major 
chronic diseases, such as congestive heart failure, 
hepatic cirrhosis, renal insufficiency, and diabetes[5,6]. 
Data from an international survey on 1966 responding 
IBS patients (83% female, 91% white, 78% United 
States/Canada), stressed the relevance of impaired 
health status: restriction of 73 d/year of activity on 
average, poor health-related quality of life, particularly 
with dietary restrictions, mood disturbance, and 
interference with daily activity. To receive treatment 
that would make them symptom-free, patients would 
give up 25% of their remaining life (average 15 years), 
and 14% would risk a 1/1000 chance of death[7]. 
In addition, this condition represents an economic 
burden to society as a result of the low productivity 
of IBS patients and the excessive use of healthcare 
resources[8,9]. Conventional IBS treatment consists 
of antispasmodics, antidepressants, and medications 
modifying bowel habit, depending on whether diarrhea 
or constipation is the predominant disorder. The 
notorious long-term inadequacies of current drug 
therapy lead to much patient dissatisfaction, and a 
tendency for patients to seek a variety of alternative 
remedies, especially of a dietary nature[10,11], because 
20%-65% of them attribute their symptoms to 
adverse food reactions[12-14]. However, there are 
surprisingly few studies focusing on the relationship 
between IBS symptoms and diet, thus this issue is still 
controversial[15-23]. This represents a glaring gap that 
needs to be addressed.
METHODOLOGY OF THE REVIEW
Recently published data on the relationship between 
gastrointestinal functional disorders (including IBS) 
and adverse food reactions showed that the number 
of studies has increased since 2000: from 54 to 77 
publications per 2.5-year interval for “adverse food 
reactions”, and from 454 to 991 for “food allergy”, up 
to June 2013[24]. The present review aims to elucidate 
the role of diet in the pathogenesis of IBS and the 
importance of dietary factors in the management of 
these patients. We searched the MEDLINE electronic 
database (1966 to Jan 2015) using the following 
keywords alone and in different combinations: “food”, 
“diet”, “food allergy”, “food hypersensitivity”, “food 
intolerance”, “IBS”, “epidemiology”, “pathogenesis”, 
“pathophysiology”, “diagnosis”, and “treatment”. The 
search was restricted to papers published in English 
or at least having an abstract in English. We retrieved 
potentially relevant articles and reviewed their 
reference lists to identify studies missed by our search 
strategy. At the end of our search, we found a total 
of 153 eligible papers; 80 were excluded because: 
not written in English, exclusive biochemical and 
experimental research, case reports, reviews reporting 
data of the same original studies, and research 
otherwise not relevant to our specific interest (i.e., 
matching error). In the end we selected 73 papers, 
specifically 43 original papers, 26 reviews, and 4 
letters to editor.
IBS PATHOGENESIS: NOT ONLY 
A SOMATIZATION DISORDER
To date IBS pathogenesis remains uncertain, even 
though multiple factors, such as altered small bowel 
and/or colonic motility (slow, fast or uncoordinated), 
visceral hypersensitivity (“visceral hyperalgesia”), 
imbalance in neurotransmitters, genetic factors, 
psychological dysfunction, infections, and inflammation, 
may lead to the development and maintenance of 
symptoms[25,26].
The evidence of a correlation between IBS and the 
microorganisms that reside in the gut in physiological 
or pathological conditions has been highlighted in an 
IBS patient subgroup. Some authors point to a small 
intestinal bacterial overgrowth (SIBO)-like condition 
as one possibility, whose diagnosis is often based on 
indirect measures (lactulose breath test), leading to 
symptoms due to fermentation and gas production 
in the small intestine[27,28]. In this context, some IBS 
patients describe acute onset of persistent symptoms 
after an episode of gastroenteritis, characterized by at 
least two of the following: fever, vomiting, diarrhea, 
or positive stool culture. New IBS onset develops after 
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infective gastroenteritis in 4%-31% of people, and 
the odds of developing IBS seem to be significantly 
higher in subjects with prior gastroenteritis compared 
to controls[29-34]. These data are confirmed by the 
prevalence of post-infection IBS among patients 
with IBS that ranges between 3% and 35%[35,36]. 
Nevertheless, a simple explanation of post-infection 
IBS does not yet exist, but enteric infections surely 
affect gut physiology, causing a persistent low-grade 
mucosal inflammation in some patients[37].
Colon mucosa histology of patients with IBS who 
did not describe any pre-existing acute infection 
gastroenteritis found similar low-grade inflammatory 
changes on post-infection patients, suggesting a 
more general “inflammatory hypothesis” for IBS[38,39]. 
Furthermore, this mucosal inflammation could be a 
clue for a role of food allergy in an IBS subgroup; 
histology can be characterized by increased numbers 
of jejunum and terminal ileal mucosa mast cells[40-47], 
eosinophils[46,48,49], T lymphocytes [T helper (TH)2 and 
TH17][47,49-51], B lymphocytes and plasma cells[52]. This 
inflammatory infiltrate causes typical abnormalities on 
the intestinal nerve plexus and nociceptive structures: i.e., 
association of mast cells to enteric and colonic visceral-
nociceptive sensory neurons, unmyelinated nerves 
in the lamina propria at the ileo-caecal junction, and 
substance-P positive nerves[53-56], and direct T cell-neural 
interaction, lymphocyte infiltration in the myenteric 
plexus[57], and increased circulating gut-homing 
lymphocytes expressing β7 integrin[58]. Obviously, an 
intense pattern of expression of pro-inflammatory and 
neuro-stimulating molecules support such substantial 
change in the normal intestinal mucosa morphostructural 
framework. Specific histopathology staining has found 
increased tissue concentration of histamine (and H1R 
and H2R receptors)[59-61], serotonin[62,63], substance P, 
vasoactive intestinal peptide[64], inducible nitric oxide 
synthase (iNOS)[65,66], pro-inflammatory cytokines [i.e., 
interferon (IFN)-γ, interleukin (IL)-1β, tumor necrosis 
factor (TNF)-α, IL-4 and IL-13 [(the latter are TH2 
cytokines, leading to up-regulation of transforming 
growth factor (TGF)-β and increased cyclooxygenase-2 
and prostaglandin E2 expression within smooth muscle)], 
chemotactic chemokines [i.e., monocyte chemotactic 
protein-1 (CCL2), macrophage inflammatory protein-1β 
(CCL4), and CXCL16][67,68], and a high TNF-producer/low 
IL-10-producer cell phenotype[69]. Strengthening the role 
of inflammation, increased fecal levels of IgE, tryptase, 
eosinophil cationic protein and eosinophil protein X 
have also been found[70-74]. All these quantitative data 
suffer from a great overlap between IBS patients and 
controls; however, it is generally accepted that the 
mucosal immune system seems to be activated in at 
least a subset of patients suffering from IBS. In these 
subjects it is noteworthy that mucosal inflammation 
and local activation of the immune system can be 
attributable to either exogenous factors, including food 
antigens and changes in the resident microbial flora, 
or endogenous chemical irritants, such as bile salts. 
Mucosal immune cell activation results in changes in 
the function of submucosal and myenteric neurons, 
linking these two effector systems in the genesis of 
gastrointestinal function disorders (e.g., intestinal 
permeability, secretion, absorption, blood flow, visceral 
sensitivity, and motility)[33,38,39,74,75].
On the other hand, the classical pathogenic 
hypothesis is that IBS represents a disturbance of 
the “brain-gut axis”, referring to the bi-directional 
communication between the gut (luminal wall and 
enteric nervous system) and the central nervous 
system, including the hypothalamic-pituitary axis. 
In this context female gender, family history of IBS, 
history of physical or sexual abuse, and co-morbid 
psychiatric disorders are strong IBS risk factors. In 
addition, up to 70% of the patients referred to tertiary 
centers with IBS meet diagnostic criteria for anxiety or 
depression[76-78]. However, a link between this “classical 
pathogenesis” and inflammation exists. Some studies 
sustain that stressful early life events and/or psychiatric 
co-morbidity mediate low-level inflammation and 
mast cell and lymphocyte infiltration of the bowel. 
Many studies on IBS link the events observed at the 
cellular level to anxiety and depression. Increased 
gastrointestinal symptoms, due to stronger intestinal 
cell immune activity, are directly linked to anxiety 
and depression. Furthermore, a certain correlation 
has been shown between inflammatory cytokine 
release (IL-1β, IL-6, and TNF-α,) and mood. These 
data support the histopathology evidence promoting 
the idea of a three-way relationship between IBS (as 
well as other functional gastrointestinal disorders), 
mood disturbance, and immune dysregulation[79-81]. 
Further complicating this framework is the established 
existence of a complex immune response system, which 
cannot be reduced only to TH1 and TH2 responses, but 
includes several pathways described as a mosaic of 
overlapping TH1/TH2 responses mediated by TH17 and 
TH22 cells[82].
ATOPY AND IBS
It has been suggested that IBS, and its related low-
grade inflammation, can be the expression of a 
systemic allergic (or “atopic”) disorder induced by 
foods (food allergy or food hypersensitivity). Several 
lines of evidence support this hypothesis (Table 
1). An increased airway responsiveness to inhaled 
methacholine and/or reversibility with bronchodilators 
has been shown in IBS patients with no clinical 
evidence of asthma or other atopic disease compared 
to control groups (i.e., positive disease controls with 
inflammatory bowel disease and healthy controls)[83,84]. 
Nevertheless, contrasting data come from a study 
on 42 IBS patients and 42 matched healthy controls 
that does not confirm increased bronchial hyper-
responsiveness[85].
Analysis of this same issue from the opposite point 
of view has evidenced that patients with bronchial 
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Ref. Study design Patients Topic Main results
White et al[83], 1991 Case-control 
observational 
study
11 IBS patients
11 healthy 
controls
11 organic gut 
diseases patients
IBS and 
bronchial hyper-
responsiveness
FEV1 reduction induced by methacholine in IBS patients was 
significantly greater than that observed in healthy subjects. FEV1 
decrease in patients with organic disease was not different from 
that in normal subjects
Yazar et al[84], 2001 Case-control 
observational 
study
133 IBS patients
137 healthy 
controls
IBS and asthma Twenty-one (15.8%) IBS patients and 2 (1.45%) patients from the 
control group had the diagnosis of asthma. FEV1, flow after 50% of 
the vital capacity has been exhaled, peak expiratory flow rate, and 
maximal mid-expiratory flow rate were significantly different
Jun et al[85], 2005 Case-control 
observational 
study
42 IBS patients
42 healthy 
controls
IBS and 
bronchial hyper-
responsiveness
No statistical difference was found between the two groups with 
respect to FEV1, FVC, FVC/FEV1, and FEF(25-75)
Roussos et al[86], 2003 Case-control 
observational 
study
150 asthma 
patients
130 other 
pulmonary 
disease patients
120 healthy 
controls
IBS and asthma IBS prevalence was significantly higher in asthmatics (62/150, 
41.3%) than in subjects with other pulmonary disorders (29/130, 
22.3%) and healthy controls (25/120, 20.8%). None of the asthma 
medications were associated with increased or decreased likelihood 
of IBS
Ozol et al[87], 2006 Case-control 
observational 
study
125 asthma 
patients
95 healthy 
controls
IBS and asthma IBS was found in 29.6% and 12.7% (P < 0.005) respectively of asthma 
patients and healthy controls. Food allergy was reported in 7.2% 
and 2.1% (P > 0.05) respectively for the two groups. No significant 
association between asthma related parameters, IBS, and food 
allergy could be found
Powell et al[88], 2007 Retrospective 
study
7235 patients 
attending a 
general practice
IBS, asthma and 
allergic rhinitis
IBS was more common in patients with asthma (9.9%) and allergic 
rhinitis (7.9%) compared to patients with chronic diseases (4.9%, P < 
0.002 and 4.9%, P < 0.05 respectively) or the remaining non-asthmatic 
population (5.5%, P < 0.001 and 5.5%, P < 0.02 respectively)
Cole et al[89], 2007 Nested case-
control study
91237 people with 
asthma
24518 people 
without asthma
IBS and asthma Incidence of IBS among people with asthma was 20% higher than 
in non-asthmatic patients; no association was found between oral 
steroid intake and IBS among people with asthma
Huerta et al[90], 2002 Population-based 
cohort study
50000 people with 
asthma
50000 people 
without asthma
IBS and asthma IBS incidence in the asthma cohort was 2.5 per 1000 persons/years 
and 2.0 in the general population, with a RR of 1.3. In the asthma 
cohort, oral steroid users had RR of 0.5 for developing IBS, without 
any difference between short- and long-term users
Panicker et al[91], 2008 Case-control 
observational 
study
138 asthma 
patients
145 healthy 
controls
IBS and asthma A large proportion (39.13%) of asthmatics had IBS compared to 
controls (7.93%) (P < 0.001). IBS was reported in 87% of cases using 
inhalers, and in 13% with additional oral theophylline (P < 0.001). 
As many as 66.6% cases, had IBS with relatively short duration of 
asthma (1-5 yr, P < 000)
Hunskar et al[92], 2012 Cohort study 817 subjects 
exposed to giardia
1128 subjects not 
exposed to giardia
Post-infection 
IBS and asthma
IBS was found in 47.8% of subjects with asthma compared with 
45.3% in those without asthma (P = 0.662) in the giardia exposed 
group. For controls, corresponding percentages were 23.9% and 
12.2% (P < 0.001)
Tobin et al[93], 2008 Prospective study 125 consecutive: 
allergy/
immunology 
(n = 39), 
gastroenterology 
(n = 36)
general medicine 
(n = 50)
IBS and atopic 
diseases
The likelihood of IBS was significantly higher in patients with 
seasonal allergic rhinitis (2.67 times; P = 0.03), allergic eczema (3.85 
times; P = 0.001), and depression (2.56 times; P = 0.04). Patients 
reporting atopic symptoms (seasonal allergic rhinitis, asthma, and 
allergic eczema) were 3.20 times (95%; P = 0.02) more likely to fulfill 
IBS criteria
Jones et al[94], 2014 Retrospective 
study
30000 patients 
from primary care 
medical records
FGIDs and atopic 
diseases
In patients suffering from IBS alone, functional dyspepsia alone 
and multiple functional gastrointestinal disorders, there was higher 
asthma prevalence compared to controls (OR = 1.43, 1.41 and 1.92 
respectively)
Olén et al[96], 2014 Birth cohort study 2610 children Recurrent 
abdominal 
pain and atopic 
diseases in 
children
237 (9%) children reported abdominal pain when 12 yr old. Asthma 
in the first two years of life and food allergy at age 8 yr were 
significantly associated with abdominal pain at 12 yr (P < 0.001). 
There was an increased risk of abdominal pain at 12 yr in children 
sensitized to food allergens at 4 or 8 yr
Smith et al[97], 1985 Prospective study 29 patients with 
perceived food 
hypersensitivity
Self-
reported food 
hypersensitivity 
and allergy
17 (60%) of the 26 patients were positive to skin prick tests to 
inhalant allergens
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Lillestøl et al[98], 2010 Prospective study 71 patients with 
perceived food 
hypersensitivity
Self-reported food 
hypersensitivity 
and allergy
66 (93%) patients suffered from IBS and 43 (61%) had atopic 
diseases (predominantly rhinoconjunctivitis). Atopic patients had 
increased density of IgE-bearing cells and intestinal permeability 
but gastrointestinal symptoms did not differ between groups (P = 
0.02). IgE-positive cells and intestinal permeability did not differ 
between patients who were sensitized to inhalants and those who 
were only sensitized to food
Berstad et al[99], 2012 Prospective study 84 patients with 
perceived food 
hypersensitivity
Self-reported food 
hypersensitivity, 
IBS, chronic 
fatigue and 
fibromyalgia
83 patient were diagnosed with IBS, 58% with severe symptoms. 
85% reported symptoms suggestive of chronic fatigue and 71% 
fibromyalgia. These symptoms could not be explained either by 
IgE-mediated food allergy or by organic pathology
Lind et al[100], 2013 Case-control 
observational 
study
38 patients with 
self-reported food 
allergy
42 healthy 
controls
Self-reported food 
hypersensitivity, 
IBS, fatigue
FIS scores were higher in patients (median 85.0, interquartile range 
36.8-105.3) than in controls (median 14.0, interquartile range 3.0-29.0, 
P ≤ 0.0001)
McKee et al[12], 1987 Observational 
study
40 IBS patients IBS and 
elimination diet
Patients received an antigen-exclusion. 15% showed improvement 
in their IBS-symptoms. A further 12.5% reported increased well-
being but this did not seem to be related to the exclusion of any 
particular food. The diarrhea prevalent subgroup responded the 
best (3/8) whereas the constipation subgroup consistently failed to 
improve
Heizer et al[17], 2009 Review NA IBS and 
elimination diet
25% of IBS patients reported their symptoms may be caused or 
exacerbated by one or more dietary components. Diet restricted in 
fermentable, poorly absorbed carbohydrates, including fructose, 
fructans, sorbitol, and other sugar alcohols seemed to be beneficial
Zar et al[101], 2005 Prospective study 25 IBS patients IBS and 
elimination diet
Patient IgG4 antibodies to milk, eggs, wheat, beef, pork and 
lamb were measured, and were commonly elevated. Significant 
improvement was reported in pain severity (P < 0.001), pain 
frequency (P = 0.034), bloating severity (P = 0.001), satisfaction with 
bowel habits (P = 0.004) and effect of IBS on life in general (P = 0.008) 
at 3 and 6 mo of elimination diet
Atkinson et al[102], 2004 Randomized trial 150 IBS patients IBS and 
elimination diet
Patients received either a diet excluding all foods to which they had 
raised IgG antibodies or a sham diet for 3 mo. The true diet resulted 
in a 10% (26% in fully compliant) greater reduction in symptom 
score than the sham diet
Bolin[103], 1980 Randomized trial 20 patients 
suffering from 
persistent 
diarrhea
IBS and DSCG 18 patients reported significant improvement in diarrhea while 
taking sodium cromoglycate and this did not correlate with the 
presence of other atopic diseases, history of food intolerance, or 
lactase deficiency
Paganelli L et al[104], 1990 Prospective study 14 IBS patients IBS, elimination 
diet and DSCG
7 (50%) patients improved after elimination diet with (5/7) and 
without (2/5) DSCG
Lunardi et al[105], 1991 Double-blind 
cross-over trial
20 IBS patients IBS and DSCG 18 patients completed the study; analysis of patients' diary card 
scores showed a statistically significant difference in favor of DSCG
Stefanini et al[106], 1992 Prospective study 101 IBS patients 
(diarrhea type)
IBS, atopy and 
DSCG
Patients were then tested for 48 commercial alimentary antigens by 
SPT and underwent 8 wk of oral DSCG. Symptom improvement 
was observed in 67% of the 74 SPT-positive patients, whereas only 
in 41% of the 27 SPT-negative patients
Stefanini et al[107], 1995 Multicenter trial 428 IBS patients 
(diarrhea type)
IBS, elimination 
diet and DSCG
IBS symptoms improved in 60% of patients treated with elimination 
diet and in 67% of those treated with DSCG. In both groups clinical 
results were significantly better in the patients positive to the skin 
prick test than in the negative ones
Leri et al[108], 1997 Randomized 
study
120 IBS patients 
(diarrhea type)
IBS, elimination 
diet and DSCG
66 patients had positive SPT; they were randomly treated with 
elimination diet (30) or with elimination diet plus DSCG. 18 (60%) 
of the 30 patients that had received the only exclusion diet reported 
symptom improvement, whereas 32 of the 36 patients (89%) who 
had undergone both dietary and DSCG treatments showed an 
improvement that was clinically and statistically significant (P = 
0.01)
DSCG: Disodium cromoglycate; FCV: Forced vital capacity; FEF: Forced expiratory flow; FEV1: Forced expiratory volume in 1 s; FGIDs: Functional 
gastrointestinal disorders; FIS: Fatigue impact scale; IBS: Irritable bowel syndrome; RR: Relative risk; SPT: Skin prick test; NA: Not available.
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asthma and allergic rhinitis (or other atopic disease) 
have higher prevalence of IBS compared to patients 
suffering from other pulmonary disorders and healthy 
subjects[86,87]. For example, Powell et al[88], in a 
retrospective case control study of more than 7000 
patients in a general practice setting in the United 
Kingdom, demonstrated an excess of IBS among 
patients with general practitioner-diagnosed allergic 
conditions (bronchial asthma and allergic rhinitis). 
The odds ratio (OR) for IBS among bronchial asthma 
patients was two-fold that of controls, indicating a 
substantial association between these conditions[88]. 
Cole et al[89] found a similar pattern for IBS prevalence 
in asthmatics; no association was found in this study 
with the asthma therapy (e.g., use of oral steroids), 
but another study showed reduction of risk of IBS 
development in asthma patients by use of oral steroids. 
These findings could suggest a beneficial effect of 
steroid treatment in IBS, thus entailing a possible role 
of inflammation in IBS pathogenesis[90]. Their findings 
were replicated by Panicker et al[91], who reported an 
OR for IBS of almost 3 in an allergy out-patient sample 
in Kuwait, and afterwards by Hunskar et al[92] in 
Norway. In 2008, a prospective study by Tobin et al[93] 
used structured questionnaires administered to 125 
consecutive patients admitted to allergy/immunology, 
gastroenterology, and general medicine clinics to 
confirm this evidence. The allergy/immunology clinic 
reported a significantly higher rate of IBS than the 
general medicine clinic, and surprisingly similar to that 
reported in the gastroenterology department. Patients 
reporting atopic symptoms (seasonal allergic rhinitis, 
asthma, and allergic eczema) were 3.20 times more 
likely (95%CI: 1.20-8.50, P = 0.02) to fulfill the criteria 
for IBS. Therefore, the authors defined a subgroup 
of IBS patients (“atopic IBS”) who have typical IBS 
symptoms in association with atopic manifestations. 
Significantly, the likelihood of IBS was significantly 
higher in patients also suffering from depression[93]. 
More recently, Jones et al[94] examined the matching 
of IBS, functional dyspepsia, and chronic idiopathic 
constipation diagnosis, with 4 atopic conditions (allergic 
rhinitis/hay fever, conjunctivitis, eczema and bronchial 
asthma) from 30000 primary care medical records in 
the United Kingdom, using the Health Improvement 
Network (THIN), over a minimum 5 year period. The 
validity of gastrointestinal disorder diagnoses has been 
shown, and the diagnostic records in THIN have been 
validated[95]. The authors considered factors known 
to be involved in functional gastrointestinal disorders, 
including age, gender and mood disorders (i.e., anxiety 
and depression) to determine whether these factors 
may explain the association. Atopic conditions were 
found in excess among all functional gastrointestinal 
disorder groups compared to controls. In particular, in 
the groups with IBS alone, functional dyspepsia alone, 
and multiple functional gastrointestinal disorders, there 
was higher asthma prevalence compared to controls. 
The excess was generally highest among patients 
with multiple functional gastrointestinal disorders, 
and was only partly explained by the “three-way 
interconnection” among functional gastrointestinal 
disorders, atopic conditions and mood disorders[94]. 
In a birth cohort study of 2610 children, Olén et al[96] 
examined the association between allergy-related 
diseases (asthma, allergic rhinitis, eczema and food 
allergy) or sensitization (i.e., allergen-specific IgE 
detection) and recurrent abdominal pain of functional 
origin, a specific phenotype of IBS in children. The 
authors showed that all allergy-related diseases were 
associated with concurrent abdominal pain and that 
the risk increased with increasing number of allergy-
related diseases. Asthma in the first two years of life 
and food allergy at age 8 years were significantly 
associated with abdominal pain at 12 years. There 
was an increased risk of abdominal pain at 12 years 
in children sensitized to food allergens at 4 or 8 years, 
but in stratified analyses, this was confined to children 
whose parents had not reported food allergy at the 
time of sensitization[96].
Another interesting field of study includes the 
patients with self-reported food allergy. In a study 
performed in patients with self-reported food allergy 
there was an increased prevalence of both IBS 
and atopic disease (e.g., bronchial asthma and 
rhinoconjunctivitis) compared to healthy subjects. 
These authors studied a small group composed of 
29 patients with perceived food allergy and IBS, and 
found a high prevalence of atopic disease: about 
60%, as defined by 3 or more positive skin prick tests 
(SPT) to inhalant allergens[97]. More recently, Lillestøl 
et al[98] explored the association between atopic 
diseases, gastrointestinal symptoms, and possible 
gastrointestinal manifestations of atopic disease in 
71 adult patients with gastrointestinal complaints 
self-attributed to food allergy. The authors evaluated 
symptoms, SPT, serum markers of allergy (total and 
specific IgE, tryptase, and eosinophil cationic protein), 
intestinal permeability, IgE- and tryptase-positive cells 
and eosinophils in duodenal biopsies. The diagnosis 
of food allergy was based on double-blind placebo-
controlled food challenges (DBPCFC), the method 
which is considered the gold standard in adverse 
food reaction diagnosis (see below). The authors 
demonstrated that 93% of the patients suffered 
from IBS and 61% patients had atopic diseases 
(predominantly rhinoconjunctivitis). Atopic patients 
had increased density of IgE-bearing cells (mainly 
mast cells) and intestinal permeability compared to 
non-atopic patients, but gastrointestinal symptoms 
(i.e., IBS-like presentation) did not differ between 
groups. IgE-sensitization was mainly against inhalants 
and pollen-associated food allergens. The numbers 
of IgE-positive cells and the intestinal permeability 
did not differ between patients who were sensitized 
to inhalants and those who were only sensitized to 
food. However, DBPCFC were negative in most of 
the patients, and the clinical significance of such 
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sensitization was uncertain. In the article, however, the 
DBPCFC challenge method was not described and this 
limits the opportunity to evaluate the results[98]. In this 
context, it has been also demonstrated that perceived 
food allergy in IBS patients may be associated with 
more severe and debilitating illness. Berstad et al[99] 
in a prospective study enrolling 84 patients referred 
for perceived food allergy assessed the severity of 
their intestinal and extra-intestinal symptoms. All 
but 1 patient were diagnosed with IBS, according to 
the Rome Ⅲ criteria. The large majority of subjects 
reported extra-intestinal symptoms; 85% reported 
symptoms suggestive of chronic fatigue, and 71% 
fibromyalgia. These symptoms could not be explained 
either by IgE-mediated food allergy or by organic 
pathology. The authors conclude that comorbidity (the 
triad of IBS, chronic fatigue, and musculoskeletal pain) 
demonstrated in 71% of examined patients, might 
be caused by a common underlying cause[99]. Lind et 
al[100] reported similar results, validating a Norwegian 
translation of the Fatigue Impact Scale (FIS); the 
impact of fatigue among 38 patients with self-reported 
food allergy and IBS was greater than among the 42 
healthy controls.
Finally, to strengthen the possible pathogenic 
association between food allergy and IBS, several 
studies demonstrated a positive response to elimination 
diets and disodium cromoglycate (DSCG)[12,17,101-108], 
suggesting that in a subset of IBS patients, symptoms 
can be attributed to food allergy.
FACTS: DIET IN IBS PATIENTS
Most patients with IBS believe that diet plays a 
significant role in their symptoms, and 63% desire to 
know what kind of foods they should avoid (15-23). 
The current medical diagnostic methods allow 
diagnosis of food allergy only in 1%-3% of them. 
This discrepancy is a major source of frustration 
both for patients and for health care professionals, 
who are unable to provide appropriate answers and 
support[109-112]. Nevertheless, several studies agree 
in reporting that 60% of IBS patients worsen their 
symptoms following food ingestion; 28% within 
15 min after eating and 93% within 3 h. Many IBS 
patients identify specific foods as responsible for their 
symptoms, most commonly implicating wheat products 
(pasta, bread, pizza), cow’s milk and milk-derived 
products, tomato, eggs, certain meats, fish/shellfish, 
cabbage, peas/beans, onion, hot spices, garlic, apple, 
peach, citrus, fried food, smoked products, fats, food 
additives, walnuts, hazelnuts, chocolate, alcohol, and 
caffeine[13,72,113-119]. Table 2 summarizes the data of the 
literature about the frequency of the different foods 
acting as trigger factors in IBS.
Böhn et al[120] examined which food groups and 
specific food items IBS patients report causing 
gastrointestinal symptoms, and investigated the 
association between gastrointestinal and psychological 
symptoms and quality of life. All of the 197 adult IBS 
patients completed questionnaires on food allergy, 
IBS symptoms, somatic symptoms, depression and 
general anxiety, gastrointestinal-specific anxiety, 
and quality of life. 84% of them reported symptoms 
related to at least one food, and over 70% noted 
symptoms after intake of food items with incompletely 
absorbed carbohydrates, i.e., Fermentable Oligo-, Di-, 
and Monosaccharides and Polyols (FODMAP), dairy 
products, beans/lentils, apple, flour, and plum. Patients 
also experienced gastrointestinal symptoms from foods 
rich in biogenic amines, i.e., histamine and tyramine, 
such as tuna, salami, cheese, and wine/beer (58%), 
or histamine-releasing foods: pork, milk, and wine/
beer (43%). More than half (52%) of IBS patients also 
considered fried and fatty foods as possible symptom 
triggers. The authors concluded that self-reported 
food allergy was associated with reduced quality of 
life (sleep, physical status and social interactions)[120]. 
Similarly, Carlson et al[121] studied perceived food 
allergy in 25 child-parent pairs through a questionnaire 
and focus groups. The majority of children participating 
were classified as either having IBS or abdominal 
migraine. The median number of foods identified as 
producing gastrointestinal symptoms was 11, and 
the top 3 self-identified trigger foods were spicy 
foods, pizza and cow’s milk. Children identified coping 
strategies, including eating smaller portions, modifying 
foods, or avoiding the food altogether. Interestingly, 
all of them reported a certain degree of impairment in 
school performance, sports, and social activities[121].
Such evidence indicates a certain selectivity in 
dietary intake in IBS patients with perceived food 
allergy, but no difference was detected between them 
and community health controls by dietary survey[122-126]. 
On the other hand, a Norwegian population-based 
cross-sectional study on food allergy and IBS showed 
that 70% of subjects perceived a food allergy (mean 
4.8 food items related to symptoms), 62% limited 
or excluded food items from their daily intake (mean 
2.5 food items reduced or eliminated), and 12% 
made drastic changes in their diet potentially causing 
nutritional deficiencies in the long run. However, no 
association was pointed out among perceived food 
allergy, food allergy diagnostic tests (i.e., serum total 
IgE and food-specific IgE, IgA antibodies against 
lactalbumin, lactoglobulin, casein and ovalbumin, total 
IgA, IgA and IgG against gliadin and gluten), and 
lactose malabsorption (H2 and CH4 breath test)[127]. 
Data that are fairly consistent in the already mentioned 
studies, and in many others, confirm the lower 
consumption of spaghetti, pasta, couscous, and rice in 
IBS than in controls. The first three are products made 
using durum wheat, which tend to be high in gluten 
and FODMAP, while rice tends to be low[128,129]. Another 
common belief is that lactose could be the main cause 
of IBS symptoms. Therefore these patients consume 
less milk and other dairy products[128,130-132], but it 
must be remembered that dairy products represent 
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Table 2  Identification of foods triggering symptoms in irritable bowel syndrome patients
Ref. Patients Diagnostic methods Foods Comment
Nanda et al[13], 1989 91 of 200 IBS patients 
reported symptomatic 
improvement after 3 wk 
of elimination diet
Open challenge Cheese 35.2%
Onions 35.2%
Milk 31.9%
Wheat 29.7%
Chocolate 27.5%
Butter 25.3%
Yoghurt 24.7%
Coffee 24.2%
Eggs 23.3%
Nuts 18.0%
Others 34.1%
73 of the 91 improved patients were able to 
identify one or more foods responsible for 
their symptoms in the open challenge. All 
except one remained well on clinical follow-
up
Carroccio et al[71], 2011 160 IBS patients DBPCFC to wheat 
and milk
Wheat and milk 18.75%
Only milk 3.75%
Only wheat 2.5%
40 (25%) patients were found to suffer from 
food hypersensitivity. These patients had 
increased levels of fecal eosinophil cationic 
protein and tryptase, indicating that they 
might cause inflammation in patients with 
IBS
Dainese et al[112], 1999 128 IBS patients Self-reported 
intolerance 
questionnaires vs 
SPT
Milk (28.8% vs 3%)
Wheat (17.5% vs 1.5%)
Pepper (2.5% vs 6%)
Peanut (6.3% vs 6%)
Pear (5% vs 7.5%)
Tomato (12.5% vs 9%)
Onion (3.8% vs 9%)
Celery (2.5% vs 9%)
Banana (2.5% vs 9%)
Carrot (0% vs 10.5%)
Garlic (0% vs 10.5%)
Parsley (0% vs 16%)
Walnut (6.3% vs 18%)
Apple (10% vs 18%)
More than 50% of IBS patients were found 
sensitized to some food or inhalant without 
any symptom. There is a substantial lack 
of correlation between self-perceived food 
intolerance and SPT sensitization
Locke et al[115], 2000 76 IBS patients of 643 
subjects from Olmsted 
County general 
population
Self-reported 
intolerance 
questionnaires
Beans 22.3%
Chocolate 23.6%
Dairy products 52.6%
Eggs 21.0%
Nuts 23.6%
Onions 57.8%
Spicy food 81.5%
Among the 643 subjects, IBS symptoms were 
reported by 12% (76). IBS was significantly 
associated with use of analgesics, food allergy 
or sensitivity
Farah et al[116], 1985 13 of 49 patients 
suspected of food 
intolerance after 
elimination diet
DBPCFC 1/13 peas
1/13 coffee
1/13 eggs
After DBPCFC 3 patients were confirmed to 
suffer from food intolerance. Authors found 
that 10 patients reacted to placebo, suggesting 
a psychogenic cause for their disturbances
Carlson et al[121], 2014 25 children suffering 
from gastrointestinal 
disorders and their 
parents
Child-reported 
intolerance 
questionnaires vs 
parent- reported 
intolerance 
questionnaires
Spicy food 68% vs 60%
Pizza 52% vs 48%
Cow’s milk 56% vs 48%
Fired foods 48% vs 36%
Fast Foods 40% vs 40%
Sodas 40% vs 36%
Cheese 40% vs 36%
Specific foods are perceived to exacerbate 
gastrointestinal symptoms in children 
with functional gastrointestinal disorders. 
No differences were found in severity or 
frequency of symptoms with ingestion of 
the foods between children and parents with 
respect to the 10 most frequent foods/food 
types
Böhn et al[126], 2013 197 IBS patients Self-reported 
intolerance 
questionnaires
Dairy products 49.2%
Beans 36.0%
Apple 27.9%
Wheat 24.4%
Fried foods 52.3%
Plum 23.4%
Peas 19.3%
Chocolate 16.8%
Foods rich in biogenic amines 
(58%)
Histamine-releasing foods 
(43%)
Most IBS patients believe that certain foods 
could be triggers of their symptoms. They 
identified FODMAP containing foods, 
histamine-releasing foods, fried foods and 
foods rich in biogenic amines as the main 
culprits. Self-reported food intolerance seems 
to be associated with high symptom burden 
and reduced quality of life
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the most important daily-required dietary source 
of calcium (50%-75%), phosphorus (20%-30%), 
and vitamin B2 (riboflavin) (30%) in the Western 
world[133]. Trying to compensate for this restriction, IBS 
patients are counted among the major consumers of 
alternative milk products (soy, rice and oat milk)[128,134], 
but despite such replacement, IBS patients were 
found to have a low intake of calcium, phosphorus and 
vitamin B2[128,134]. Furthermore, IBS patients reported 
a lower consumption of certain vegetables (tomatoes, 
raw vegetables, raw broccoli, cabbage, mushrooms, 
green beans, onion, leeks, garlic, and paprika)[128,134]. 
This is most likely the reason for the significantly lower 
intake of retinol (vitamin A) equivalent, β-carotene 
and magnesium observed in these patients[128,134]. 
Controversially, they report a higher consumption 
of pears, peach, grapes, melon, mango, and plums; 
these fruits and vegetables are rich in FODMAP and 
documented as possible symptom trigger factors[128,134].
Finally, due to self-reported intolerance to various 
alcoholic beverages, lower alcohol consumption was 
found in IBS subjects, and as many as 12% either limit 
or avoid such beverages[117,127,128]. However, this latter 
evidence does not enjoy complete agreement among 
physicians. Two studies reported equal or higher 
alcohol intake in IBS patients than in the general 
population[135,136].
In conclusion, the total intake of calories, carbohy-
drates, proteins and fat does not seem to differ in IBS 
and the general population, whereas the former tend 
to avoid certain food items rich in gluten and FODMAP, 
even if the higher consumption of some FODMAP-
rich fruits and vegetables remains questionable. Such 
dietary restrictions could be responsible for their 
low calcium, phosphorus, vitamin B2, and vitamin A 
intake.
FOOD ALLERGY AND IBS
IgE-mediated allergic food reactions
There is no consistent evidence and only conflicting 
data for a role of IgE-mediated allergic response in 
IBS, perhaps especially in patients with concomitant 
atopy. Among the first studies evaluating a possible 
association, Petitpierre et al[137] analyzed 24 IBS 
patients, 12 atopic (i.e., allergy prone) and 12 non-
atopic, who underwent total serum IgE test, SPT, 
radioallergosorbent test (RAST) to various food 
allergens, and 3 wk of low-allergenic diet followed by 
open challenge. Responders underwent blind dietary 
provocation. In 14 patients one or more foods and food 
additives produced the typical IBS symptoms. Nine 
Monsbakken et al[127], 2006 84 IBS patients Self-reported 
intolerance 
questionnaires
Milk 41.7% 70% of subjects perceived a food intolerance 
(mean 4.8 food items related to symptoms), 
62% limited or excluded food items from their 
daily intake (mean 2.5 food items reduced or 
eliminated), and 12% made drastic changes 
in their diet potentially causing nutritional 
deficiencies in the long run
Cheese 14.3%
Eggs 11.9%
Peas 21.4%
Onions 35.7%
Cabbage 34.5%
Wheat 14.3%
Coffee 26.2%
Chocolate 25.0%
Beer 16.9%
Parker et al[130], 2001 122 IBS patients LHBT, lactose 
elimination diet 
and DBPCFC (with 
5/10/15 g of lactose)
33/122 (27%) positive to LHBT
9/33 (27.7%) improved on 
lactose elimination diet
5/9 (55.5%) worsened on 
DBPCFC with 15 g of lactose
Lactose intolerance was demonstrated in IBS 
patients with positive (33/122) or negative 
(13/122) LHBT. DBPCC were inconclusive
Yang et al[131], 2013 60 IBS patients vs 60 
controls
LHBT and self-
reported lactose 
intolerance
18% vs 3% with 10 g LHBT
47% vs 22% with 20 g LHBT
85% vs 68% with 40 g LHBT
63% vs 22% with self- reported 
intolerance
The risk of lactose intolerance is related to the 
dose ingested and is higher in IBS patients 
than in controls. Self-reported intolerance is 
associated with avoidance of dairy products
Dainese et al[132], 2014 51 IBS patients LHBT (50 g) and 
self-reported lactose 
intolerance
21/51 (41.1%) self-perceived 
lactose intolerance
24/51 (47%) positive LHBT
14/51 (27.4%) reported 
symptoms during LHBT
Patients who experienced symptoms during 
LHBT had more severe IBS symptoms and 
higher anxiety, depression, and fatigue scores. 
Increase in hydrogen production and in the 
severity of IBS influenced the symptoms of 
lactose intolerance during LHBT
Carroccio et al[145], 2010 24/120 IBS patients who 
underwent DPBCFC 
after elimination diet
DBPCFC and flow-
CAST
12.5% cow milk only on 
DBPCFC
8.3% wheat only on DBPCFC
79.1% both cow milk and wheat 
on DBPCFC
86.3% cow milk on Flow-CAST
85.7% wheat on Flow-CAST
Flow-CAST had higher sensitivity than 
serum total IgE and serum food-specific IgE, 
both in the diagnosis of cow’s milk allergy 
and wheat protein allergy. Flow-CAST 
diagnostic accuracy proved higher than the 
two traditional techniques both for cow’s 
milk allergy and for wheat protein allergy 
diagnoses
DBPCFC: Double blind place controlled food challenge; FODMAP: Fermentable Oligo-, Di-, and Monosaccharides And Polyols; IBS: Irritable bowel 
syndrome; LHBT: Lactose hydrogen breath test; SPT: Skin prick tests.
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of these, all from the atopy group, had elevated total 
serum IgE and positive SPT, which suggest systemic 
IgE-mediated food allergy[137]. In another study, 10 
IBS patients with atopy were included, and exposed 
by SPT to common food allergens; food allergy was 
demonstrated in 6 of them, whose symptoms improved 
on an open elimination diet. However, subsequent 
rechallenge with the offending food allergens failed to 
produce IBS symptoms[138]. Barau et al[139] examined 
the intestinal permeability of 17 children with clinical 
symptoms of IBS, analyzing the differential urinary 
elimination of lactulose and mannitol, orally ingested at 
the same dosage. Patients were tested first in fasting 
condition, then after specific food ingestion (selected 
on a suggestive clinical history or positive SPT and 
RAST). Nine patients had modification of intestinal 
permeability after food ingestion. All had a personal 
and/or family history of allergy and/or high total IgE, 
and responded to food exclusion[139]. André et al[140] 
showed increased IgE fragment crystallizable (Fc) in 
fecal extracts of 236/312 food allergy patients (73%) 
whose diagnosis was based on history, positive SPT 
and RAST. In contrast, all the 95 healthy subjects had 
undetectable fecal IgE Fc. In the subgroup analysis 
of IBS patients, 22 of the 32 (68.8%) were found to 
have detectable IgE Fc in feces. The simultaneous 
measurement of α-1-antitrypsin in the serum and 
feces excluded the possibility of plasma protein 
(including IgE) extravasation as responsible for these 
findings[140].
Bischoff et al[14] examined 375 adult patients in 
a gastroenterology outpatient clinic by history, SPT, 
measurements of laboratory parameters, and intestinal 
provocation with food allergens by colonoscopy. Thirty-
two percent of subjects complained of abdominal 
symptoms as a consequence of an adverse food 
reaction. According to clinical signs of atopic disease, 
elevated total IgE, specific IgE against food allergens, 
eosinophilia and responsiveness to DSCG, 14.4% of 
them were suspected of suffering from a food allergy. 
The diagnosis was confirmed in 3.2% by endoscopic 
allergen provocation (see below), and/or elimination 
diet and rechallenge[14]. A different approach to show 
IgE involvement in IBS was applied by Simonato 
et al[141], who examined the sera of 20 patients, 
previously diagnosed as suffering from IBS and 
complaining of symptoms after wheat ingestion (with 
symptom improvement on elimination diet and their 
re-appearance after open wheat challenge). Even 
though only 50% of them were positive for wheat-
specific IgE detection by SPT and ImmunoCAP system, 
immunoblotting analysis established that all had IgE 
binding to soluble and insoluble wheat proteins. The 
authors concluded that conventional methods used 
for the diagnosis of IgE-mediated hypersensitivity 
are inadequate for the allergological screening of this 
subgroup of patients. Two hypotheses were proposed 
to explain these results: (1) low serum specific IgE 
levels; and (2) inadequate allergenic preparations 
currently used for SPT and CAP for the diagnosis of 
food allergy to wheat. If correct, such hypotheses 
would explain why wheat IgE-mediated enteropathy 
has been rarely reported, opening a new perspective 
on the prevalence of food allergy in IBS patients[141]. 
Conflicting data come from Dainese et al[112], who 
demonstrated self-reported adverse reactions to one or 
more foods in 62.5% of 128 consecutive IBS patients, 
but with significant discrepancy between the reported 
food allergy and sensitization test findings (i.e., SPT). 
The same discrepancy was found by Jun et al[142], who 
evaluated the results of the SPT for foods and inhalant 
allergens in 105 subjects forming three different target 
groups: treated group, undergoing treatment for 
IBS due to more severe symptoms, untreated group 
whose IBS symptoms did not require treatment, and 
control group with no IBS symptoms. SPT results 
were positive in 38.6% of treated IBS patients, 16.1% 
of untreated IBS patients, and 3.3% of controls (P 
< 0.01). Patients reported being intolerant to dairy 
products, raw foods, spicy foods, coffee, and alcohol. 
On the contrary, SPT were positive for saury (a fish 
belonging to Scomberesocidae), rice, mackerel, buck-
wheat, sweet potatoes, celery, onions, and trumpet 
shell, so no correlation was found between patient’s 
allergy and SPT results[142]. A Brazilian study, by Soares 
et al[143], examined the cutaneous response to 9 food 
allergens in 43 volunteers (students and employees 
of the School of Medicine of Universidade Federal 
Fluminense). Participants were divided into 3 groups 
according to Rome Ⅱ criteria: group Ⅰ (IBS), group Ⅱ 
(functional dyspepsia), and group Ⅲ (healthy controls). 
SPT were positive in 19.4% of group Ⅰ, 2.3% of group 
Ⅱ, and 4% of group Ⅲ, with significant differences 
between the number of positive responses obtained 
in group Ⅰ (IBS) and the other 2 groups. However, 
none of the volunteers with IBS reported allergy to 
any isolated food. Authors concluded that higher 
reactivity to food antigens in group Ⅰ suggests that 
intestinal permeability may be greater in patients with 
IBS[143]. Uz et al[144], who evaluated SPT to 11 common 
allergens, total IgE, eosinophilic cationic protein and 
eosinophil counts in 100 Turkish patients satisfying 
the Rome Ⅱ criteria and 25 healthy controls, obtained 
similar results in a completely different geographic 
area. IBS patients were divided according to their main 
clinical feature (53 had constipation predominant, 19 
had diarrhea predominant, and 28 had alternating type 
IBS). The authors found that SPT positivity, mean IgE, 
and eosinophilic cationic protein were more common in 
patients than in controls, but no statistically significant 
difference could be shown between IBS subgroups. 
SPT are positive with foods rich in dietary fiber (such 
as cereals, fruits and vegetables), gas-producing 
agents (such as cereals and onion), or foods containing 
significant amounts of carbohydrates (i.e., fructose or 
sorbitol), which may be incompletely absorbed (such 
as apple, banana, and strawberry)[144].
The inadequacy of the conventional methods 
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(SPT and serum food allergen-specific IgE levels) to 
identify IgE-mediated responses in IBS patients could 
probably explain our results in a recent study[145]. 
We evaluated the efficacy of an in vitro basophil 
activation assay in the diagnosis of food allergy in 120 
consecutive IBS patients. In addition, we included as 
control groups 40 healthy subjects, and 40 patients 
suffering from gastrointestinal disorders other than 
IBS. Flow cytometric basophil activation test (Flow-
CAST) is a diagnostic allergological technique based on 
the demonstration of altered membrane phenotypes 
on allergen-activated basophils, with up-regulation, 
surface expression, and cytofluorometric detection 
of CD63[146]. Severity of symptoms and possible self-
perceived food allergy were assessed by 2 predesigned 
questionnaires. All the enrolled patients underwent 
preliminary serum total and food allergen-specific IgE 
determination, together with the Flow-CAST, and then 
underwent a 4-wk elimination diet, with the exclusion 
of wheat, cow’s milk, eggs, tomato, chocolate, and any 
other self-reported food intolerance. Patients reporting 
symptom improvement after elimination diet (44/120, 
26%) underwent DBPCFC with wheat and cow’s milk 
(1 wk wash-out interval between the two challenges). 
The 24 patients who had positive DBPCFC (3 only to 
cow’s milk, 2 only to wheat, and 19 to both cow’s milk 
and wheat) were diagnosed as suffering from IBS and 
food allergy. Comparing the results of immunologic 
assays in the different groups we found a higher 
sensitivity of Flow-CAST vs serum total IgE and serum 
food-specific IgE, both in the diagnosis of cow’s milk 
allergy and wheat protein allergy. Similarly, diagnostic 
accuracy of Flow-CAST proved higher than the two 
traditional techniques both for cow’s milk allergy and 
wheat protein allergy diagnoses. We concluded that as 
already shown for some inhalant IgE-mediated allergic 
reactions[146-148], this diagnostic test might supplement 
or better replace routine allergy tests (SPT and serum 
total and allergen-specific IgE) for the diagnosis of 
IgE-mediated food allergy[145]. Unfortunately, even if 
promising, this diagnostic technique has limitations 
since its effectiveness is quite variable. In particular, 
some years after our first study, we compared the 
diagnostic accuracy of two different methods of in 
vitro basophil activation tests: we used the first in 
the previous mentioned study, which was performed 
on blood samples after centrifugation and leukocyte 
separation, while the second was performed on whole 
blood samples. We found that in food allergy diagnosis, 
basophil activation test on separate leukocytes had a 
sensitivity of 86% and a specificity of 91%, whereas 
the test on whole blood had a sensitivity of 15%-20% 
and a specificity of 73% (P < 0.0001 compared to the 
other method)[149].
Is there a role for local IgE-mediated reactions in IBS?
To our knowledge, no other study since 2007 has 
investigated the possible relationships between 
IBS and IgE-mediated food allergy by using SPT 
for serum food-specific IgE detection. Therefore, 
the question remains open. In addition, some data 
suggest a different mechanism from the classic type-1 
hypersensitivity reactions in intestinal IgE-mediated 
food allergy in IBS patients. It has been proposed 
that an IgE-mediated reaction could be localized and 
limited to the intestinal mucosa.
In 1997 Bischoff et al[150] questioned this hypothesis, 
performing the colonoscopic allergen provocation 
(COLAP) test on 70 adult patients with abdominal IBS-
like symptoms, suspected of being related to food 
allergy, and 5 healthy volunteers. Food allergens were 
selected according to the patient’s history of food 
allergy and presence of specific IgE in serum. In the 
5 healthy volunteers a standard set of three allergens 
(milk, wheat, hazelnut) was used for challenge. All 
enrolled subjects underwent colonoscopy during which 
3 food allergens were injected into the cecal mucosa. 
The mucosal wheal and flare reaction were semi-
quantitatively classified 20 min after challenge using 
a 0-4 scale and reaction was classified as positive 
for grade ≥ 2. In 74% of subjects with a putative 
diagnosis of IBS, COLAP test was positive in response 
to at least one food allergen. In contrast, no reaction 
was detected in the 5 healthy volunteers. Biopsies 
from the positive test site showed both mast cell and 
eosinophil activation. Consequently, COLAP positive 
subjects underwent 3 mo of dietary elimination of 
suspected food allergens; 89% reported a significant 
clinical response. COLAP results strongly correlated 
with positive history of food allergy, but poorly with 
SPT results and specific serum IgE levels. These 
findings strengthen the idea of a local IgE mediated 
mechanism, which can be identified by the COLAP 
test but not by SPT and measurement of specific 
serum IgE[150,151]. Similarly, Lidén et al[152] evaluated 
the mucosal response (i.e., nitric oxide production and 
myeloperoxidase release, measured using the mucosal 
patch technique) to a rectal challenge with cow’s milk 
protein (CMP) in 21 patients with primary Sjogren’s 
syndrome and 18 healthy controls. An inflammatory 
response after CMP challenge was identified in 
38% of patients as a sign of CMP sensitivity not 
linked to serum IgE or IgG/IgA antibodies to milk 
proteins. All CMP sensitive patients suffered from 
IBS, diagnosed according to Rome Ⅲ criteria. Half 
of the positive patients had already suspected that 
their gastrointestinal symptoms could be induced 
by CM intake[152]. In three different studies Arslan 
et al[153-155], used endosonography, transabdominal 
ultrasonography and magnetic resonance imaging to 
visualize local intestinal reactions in response to direct 
intraduodenal administration of suspected allergens 
(luminal provocation). The challenge caused a rapid 
intestinal reaction, characterized by thickening of the 
intestinal wall, increased peristalsis, and influx of large 
amounts of fluid into the lumen. Notably, the latter 
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event is a typical feature of immediate IgE-mediated 
food allergy responses, due to degranulation and 
release of mediators from mucosal mast cells[156]. In 
the same way, Fritscher-Ravens et al[157] examined 
structural/functional changes of intestinal mucosa after 
food challenge in 36 IBS patients with suspected food 
allergy, and in 10 patients with Barrett’s esophagus 
(controls without IBS symptoms), using confocal laser 
endomicroscopy (CLE), for real-time visualization. 
Diluted food allergens (wheat, soy, cow’s milk, and 
yeast) were directly administered to the duodenal 
mucosa through the endoscope working channel. CLE 
showed a real-time response (i.e., epithelial breaks/
leaks/gaps forming, inter-villous space widening 
[possibly results in increased permeability], and IEL 
increase) in 22 of 36 patients (CLE+); the remaining 
14 patients (CLE-) and controls had no response to 
the challenge. Symptom scores improved more than 
50% in CLE+ patients after a 4-wk exclusion diet 
and increased up to 74% at 12 mo; as expected, 
symptoms continued in CLE- patients[157]. This might 
exclude a possible placebo effect of the exclusion diet 
because classic placebo-controlled studies have shown 
that in IBS the placebo effect is generally shorter-
lived[158]. In addition, considering that many of the 
examined patients had known non-gastrointestinal 
atopic disease, it is likely they could have a high 
density of IgE-armed mast cells in their duodenal 
mucosa; thus, a local IgE-mediated reaction seems 
an even more reasonable explanation of the visualized 
changes[98]. A demonstration of in situ induction 
of IgE without systemic IgE responses has been 
suggested by the evidence of a localized mucosal up-
regulation of IL-4 and ε germline transcripts in food 
allergy. Coëffier et al[159] suggest in their study that 
circulating immunoglobulin analysis may provide 
misleading insights into genuine mucosal allergic 
responses. Further uncertainty is added by findings on 
abdominal ultrasound assessment following duodenal 
allergen challenge, which suggest the unreliability 
of DBPCFC in identifying genuine intestinal allergic 
responses. Abnormal findings of duodenal wall swelling 
and fluid exudation were seen not only in patients 
with positive DBPCFC, but also in several DBPCFC 
negative symptomatic patients. It is thus possible that 
organic symptoms due to genuine mast cell-mediated 
mucosal allergic responses may be misdiagnosed as 
psychologically-mediated in at least some patients[154].
Non IgE-mediated allergic food reactions in IBS: a role 
for IgG
Although there is no general agreement, this type of 
hypersensitivity reaction may play a role in causing IBS 
symptoms in a subset of patients. Different antibody 
classes (i.e., IgG) seem to be of some importance in 
food-related allergies in IBS. In particular, the IgG4 
subclass, which is found to be involved in some specific 
pathologic entities (e.g., autoimmune pancreatitis), 
are synthesized under the influence of TH2 cytokines 
and might induce histamine release, exactly like IgE 
antibodies[160,161]. This concept, however, seems to be 
unclear and controversial. Although several studies 
suggested that IgG and IgG4 production may be 
part of a normal immunologic response to dietary 
antigens[162-168], other studies reported that serum IgG 
and IgG4 levels are higher in patients with IBS and 
food allergy history, perhaps related to an inflamed 
or “leaky” gut. Therefore, these patients might have 
selective gut permeability to food allergens and the 
increase of food-specific IgG and IgG4 titers could be 
a specific reaction, rather than a non-specific response 
to increased gut mucosal permeability[101,102,169-174]. 
However, due to the low sensitivity or specificity of 
tests used to support this hypothesis, their clinical use 
has been proposed with conflicting results[167,175-181]. 
Finn et al[169] were the pioneers in this field, demon-
strating an increased prevalence of serum IgG 
antibodies against dietary proteins in 58 IBS patients 
compared to 46 controls, and suggesting that IgG food 
antibodies may have some role in IBS. Afterwards, el 
Rafei et al[170] compared specific IgG4 and IgE levels 
to DBPCFC in 25 patients with suspected food allergy. 
They observed increased serum IgG4 or IgE levels in 
63% of patients with a positive history of food allergy 
and either IgG4 or IgE in 91% of diagnosed patients. 
These results suggest that the combination of specific 
IgG4 and IgE antibodies to food allergens may be 
useful in evaluating patients with suspected food 
allergy[170].
Atkinson et al[102] assessed the therapeutic 
potential of dietary elimination based on the presence 
of IgG antibodies to food. Authors selected 150 IBS 
outpatients who were randomized to receive either an 
elimination diet or a sham diet for 12 wk, excluding 
the same number of foods but not those to which 
they had antibodies. After 12 wk, the IgG based 
elimination diet resulted in a 10% greater reduction 
in IBS symptom severity score than the sham diet. 
The data were significantly higher (26%) considering 
only fully compliant patients. Reduction in symptoms 
was higher in patients exhibiting a greater number 
of sensitivities, as determined by the IgG test, if 
they adhered to the true diet but not the sham diet. 
Following reintroduction of foods, more patients in the 
IgG based elimination diet group showed worsening 
of global rating than the sham diet group. The authors 
concluded that many patients with IBS would prefer 
a dietary solution to their problem rather than having 
to take medication, and the economic benefits of this 
approach to health services are obvious. It is well 
known that patients spend large sums of money on 
a variety of unsubstantiated tests in a vain attempt 
to identify dietary allergies. The results of this study 
suggest that “assay of IgG antibodies to food may 
have a role in helping patients identify candidate 
foods”[102]. However, the study was strongly criticized 
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both for including imbalanced groups and because 
IgG food antibodies were not compared between IBS 
patients and healthy control individuals[177,182].
Zar et al[101] examined 25 patients with IBS and their 
IgG4 titers to 16 foods (milk, eggs, cheese, wheat, rice, 
potatoes, chicken, beef, pork, lamb, soya bean, fish, 
shrimps, yeast, tomatoes and peanuts), evaluating the 
effect of a food-specific IgG4 antibody-guided exclusion 
diet on symptoms and rectal compliance. IgG4 
antibodies to milk, eggs, wheat, beef, pork and lamb 
were commonly elevated, and foods were excluded for 
6 mo. Significant improvement was reported in pain 
severity, pain frequency, bloating severity, satisfaction 
with bowel habits, and effect of IBS on life in general. 
Rectal compliance increased significantly, but the 
thresholds for urge to defecate/discomfort were 
unchanged. This study also suffers from the great flaw 
of control group absence[101]. In a small open label pilot 
study, Drisko et al[171] enrolled 20 patients with IBS, 
who had failed standard medical therapies, treating 
them with food elimination diets based on the results 
of serum IgG food and mold panels, followed by 
controlled food challenge. Authors obtained a sustained 
clinical response and significant improvement in 
overall well-being and quality of life[171]. Similar results 
were recently obtained in a Chinese trial. A group 
of 77 D-IBS patients and 26 healthy controls were 
tested for specific serum IgG antibodies against 14 
common food allergens. Food-specific IgG antibodies 
were identified in 50.6% patients and 15.3% controls. 
Thirty-five patients with D-IBS and food allergy (as 
identified by specific IgG antibody positivity) agreed 
to consume diets that excluded the identified food for 
12 wk. After 4 wk of dietary therapy, most symptoms 
of D-IBS had improved, and by 12 wk, all symptom 
scores (abdominal pain, bloating level and frequency, 
abdominal distension, diarrhea frequency, stool shape, 
general feelings of distress, and total symptom score) 
decreased significantly compared to the baseline[172]. 
A double-blind, randomized, controlled, cross-over 
clinical trial, composed of baseline (usual diet), first 
diet (elimination or provocation diets), and second 
diet (interchange of elimination or provocation diet) 
phases, involved 21 patients diagnosed with migraine 
and IBS. It was demonstrated that food elimination 
based on IgG antibodies in this specific subgroup 
of IBS patients may effectively reduce symptoms 
from both disorders with possible positive impact on 
the quality of life, as well as potential savings to the 
health-care system[173]. Finally, a systematic review of 
7 clinical trials showed a 15%-71% response rate to 
diet exclusion, and the most commonly incriminated 
foods included milk, wheat, eggs, potatoes, and celery. 
However, all studies had major limitations in their 
trial designs, including inadequate patient selection, 
appropriateness and duration of exclusion diets, and 
methods of food challenge[174].
The uncertainty in the measurement of IgG and 
IgG4 to identify possible food allergy is further 
increased by the discrepancy in the studies by the 
authors above. For example, Zar et al[179] examined 
108 IBS patients (52 D-IBS, 32 C-IBS, and 24 M-IBS) 
and 43 controls, measuring IgG4 and IgE titers 
and SPT to 16 common foods including milk, eggs, 
cheese, wheat, rice, potatoes, chicken, beef, pork, 
lamb, fish, shrimps, soya bean, yeast, tomatoes, 
and peanuts. IgG4 titers to wheat, beef, pork, and 
lamb were significantly higher in IBS patients than 
controls, whereas the antibody titers to potatoes, rice, 
fish, chicken, yeast, tomato, and shrimp were not 
significantly different. In addition, IgE titers showed 
no significant difference between the groups. SPT was 
positive for only a single antigen in 5 of 56 patients 
tested with the same panel of foods. Nevertheless, no 
correlation could be found between the IgG4 antibody 
elevation pattern and patient symptoms[179]. Similarly, 
Zuo et al[180] found higher titers for some food-specific 
IgG antibodies (crab, egg, shrimp, soybean, and 
wheat), in 37 Chinese subjects with IBS compared 
to 20 controls, and no significant correlation between 
symptom severity and IgG antibody titers. As in the 
Zar et al[179] study the positivity of food allergen-specific 
IgE antibodies of the two groups did not show any 
significant difference[180]. Ligaarden et al[181] designed 
a case control study, including 269 subjects with IBS 
and 277 control subjects, which, after correction for 
subject characteristics and diet, demonstrated no 
significant differences in food-specific IgG and IgG4 
antibody levels between groups. Of some interest was 
the evidence of lower IgG values against egg and beef, 
and higher values against chicken were associated 
with more severe symptoms. The authors suggested 
that subjects with severe IBS symptoms may consume 
lower quantities of egg and beef (often reported as 
offending food items) and higher quantities of chicken 
(that seems to be better tolerated) when symptoms 
are severe and may subsequently have lower levels 
of IgG against egg and beef and higher levels of IgG 
antibodies against chicken[181].
OVERALL CONSIDERATIONS ABOUT 
FOOD ALLERGY AND IBS STUDIES
Summarizing, several studies demonstrated a variable 
response rate to exclusion diets in IBS patients, 
ranging from 15%-71%; the lack of standardized 
protocols, which may influence validity of studies, 
might explain this wide range of response rate. 
Elimination diets and subsequent DBPCFC identified 
problematic foods in 6%-58% of cases, with wheat, 
milk, and eggs being the most commonly implicated 
foods. Noteworthy: lactose or other carbohydrate 
intolerance and celiac disease were not always 
excluded in these studies, so they potentially could 
be the cause of symptoms. Diarrhea-predominant 
IBS patients had a higher symptomatic response 
rate compared to other subgroups, with response to 
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diet persisting even at 1-year follow-up. However, 
inadequate patient selection, poor compliance, 
appropriateness and duration of exclusion diets, and 
methods of food challenge were major limitations 
common in almost all trial designs. The potential for 
macro- and micronutrient deficiencies resulting from 
elimination diets, may also limit their usefulness in IBS 
patients[23,136,183,184].
NON-CELIAC WHEAT SENSITIVITY AND 
IBS
The importance of food components as possible 
triggers of IBS has been particularly stressed for 
wheat[185-188]. Mullin et al[189] recently reviewed the 
dietary management of IBS patients, pointing out how 
wheat may act as symptom inducer for several reasons: 
high fructans content and other members of the family 
of highly fermentable FODMAP; autoimmune (e.g., 
celiac) disorder trigger; high IgE and non IgE-mediated 
allergenicity (among the top 8 food allergens).
In this context, gaining more attention day by day, 
is the new nosological entity known as “non-celiac 
gluten sensitivity” (NCGS)[190]. NCGS patients usually 
present with IBS-like symptoms, often associated 
with extra-intestinal manifestations, which disappear 
on a gluten-free diet. However, to date there is no 
consensus about which components of wheat might 
be responsible, and because there is no definite proof 
that gluten is really the culprit, we have suggested 
the term “non-celiac wheat sensitivity” (NCWS)[191]. 
NCWS represents an extremely widespread problem, 
whose prevalence ranges between 0.55% to 6% of 
the general United States population. Currently NCWS 
is mainly defined by “negative” criteria: physicians 
consider the diagnosis in all cases that lack the key 
CD criteria (presence of anti-tissue transglutaminase 
(anti-tTG) antibodies, and endoscopic or histologically 
significant enteropathy, i.e., Marsh 3, do not satisfy 
the criteria for IgE-mediated wheat allergy, but 
respond to wheat elimination diet (implemented in a 
blinded fashion to avoid a possible placebo/nocebo 
effect)[190,192-198]. Its onset is reported in the third-fourth 
decades of life and a study by our group, including 
the largest series of NCWS patients in the literature, 
showed a median age of 28 years[188], and a higher 
prevalence in females (male to female ratio ranging 
between 1:2.5 and 1:4)[188,190,193,199]. Symptoms and 
signs that usually characterize NCWS occur soon after 
gluten ingestion, improving or disappearing (within 
hours or a few days) on gluten withdrawal and relapsing 
following its reintroduction. Clinical presentation is a 
combination of gastrointestinal disorders and systemic 
manifestations[186,187]. In particular, gastrointestinal 
involvement consists of IBS-like symptoms, such as 
abdominal pain, bloating, and bowel habit abnormalities 
(either diarrhea and/or constipation), whereas systemic 
manifestations range from fatigue to foggy mind, 
headache and depression, joint and muscle pain, leg 
or arm numbness, dermatitis (eczema or skin rash), 
or anemia[188,190,193,199]. IBS-like symptoms are usually 
more frequent than extraintestinal ones, but most 
patients usually report having experienced at least 2 
of the extraintestinal manifestations, primarily foggy 
mind and fatigue[188,190,193,199].
Probably the main issue concerning NCWS is its 
possible pathophysiology. Wheat, and in particular 
one of its components: gliadin, is known to induce 
both autoimmune and allergic responses (Ig-E 
mediated allergic reactions), in CD and wheat 
allergy, respectively[187,200-204]. On the contrary, NCWS 
pathogenesis is still largely unknown. Among several 
pathogenic mechanisms, we might mention (1) 
activation of innate immunity mechanisms by amylase-
trypsin inhibitors (ATI); these are plant-derived 
proteins that inhibit enzymes of common parasites in 
wheat. In vitro and in vivo studies suggest that wheat 
ATI induce innate immune responses that involve 
monocytes, macrophages, and dendritic cells[205]; (2) 
gastrointestinal neuromuscular abnormalities, leading 
to smooth muscle hyper-contractility, and indirectly a 
rise in luminal water content; this mechanism could 
be linked to an HLA-restricted predisposition[206,207]; 
(3) high FODMAP content leading to increased motility 
and gas production; and (4) non IgE-mediated wheat 
allergy[188,190,193]. Recently we retrospectively reviewed 
the features of a large group of IBS-like patients, 
fulfilling the NCWS criteria. Data of 206 patients, 
previously diagnosed as NCWS and cow’s milk protein 
intolerant, who self-reported multiple food allergy, 
and 50 IBS patients were reviewed. Patients were 
diagnosed by undergoing a standard 4-wk elimination 
diet with the exclusion of wheat, cow’s milk, eggs, 
tomato, chocolate and any other self-reported food 
intolerance, followed by a DBPC wheat and cow milk 
challenge, at an interval of at least 4 wk from each 
other and always when the patients were completely 
asymptomatic. Notably, a history of food allergy 
in infancy was more frequently reported in NCWS 
patients (40/206, 19%) than in IBS controls (2/50, 4%, 
P = 0.01), as was the coexistence of an atopic disease 
(73/206, 35% and 3/50, 6% respectively; P = 0.0001). 
Similar results suggesting the hypothesis of multiple 
food allergy in such subgroups of NCWS patients, 
are: positive serum anti-gliadin IgG (134/206, 65% 
vs 7/50, 14% in IBS controls; P = 0.0001), positive 
serum anti-betalactoglobulin IgG (80/206, 39% vs 
7/50, 14% in IBS controls; P = 0.001), positive in vitro 
basophil activation assay (166/206, 80% vs 2/50, 
4% in IBS controls; P = 0.0001) and Intraepithelial 
eosinophil infiltration in the colon mucosa (154/206, 
75% vs 0/50 in IBS controls; P = 0.0001). These 
data made us conclude that patients with NCWS and 
multiple food allergy have several clinical, laboratory, 
and histological characteristics suggesting a non-IgE-
mediated food allergy[186,188].
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Finally, there is a reasonable overlap between 
NCWS and IBS and several patients classified in 
one of the two groups could be better included in 
the other. The prospective for the future is a better 
understanding of the pathophysiological background 
(similarities and differences) of the two nosological 
entities, which could facilitate the physician’s clinical 
management and improve the patient’s quality of life.
CONCLUSION
IBS affects a large proportion of the general population 
and it can significantly affect quality of life. This aspect 
is a financial burden to the national health system for 
both direct costs (estimated in the United States from 
$1562 to $7547 per year in 2013) and indirect costs 
(ranging from $791 to $7737 per year). Its etiology 
still remains elusive. The individual’s perception of 
illness, chronicity, and diagnostic uncertainty, based on 
symptom criteria alone, force physicians to undertake 
extensive and often negative investigations. Recently, 
food allergy has re-emerged as involved in many 
chronic disorders, including IBS; thus, it must be 
considered in diagnosis and management. For the 
first time, a pathophysiological basis for IBS is being 
discovered, but further work is needed to advance 
current understanding of the exact mechanisms by 
which the gastrointestinal immune system handles food 
and microbial antigens in health and disease. However, 
pending further scientific evidence, a cautious approach 
is advisable, and it should include the concept of food 
allergy as a possible cause of IBS; a dietary approach 
can find a place in routine clinical management of IBS. 
Taken together, the reported findings suggest that 
clinical management of patients with gastrointestinal 
complaints self-attributed to food should be inter-
disciplinary, attending to the gastroenterological, 
allergological, psychological, as well as dietary 
aspects of the condition. Guidance concerning food 
management, which includes individualized restriction of 
wheat and certain FODMAP-rich food items, may reduce 
IBS symptoms. However, additional research is required 
for accurate IBS diagnosis and treatment strategies.
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